SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $17.7 million in its third quarter.
The South San Francisco, California-based company said it had a loss of 14 cents per share.
The drug developer posted revenue of $900,000 in the period.
In the final minutes of trading on Tuesday, the company's shares hit $3.84. A year ago, they were trading at $2.69.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL